Trials / Conditions / Sclerosing Epithelioid Fibrosarcoma
Sclerosing Epithelioid Fibrosarcoma
4 registered clinical trials studyying Sclerosing Epithelioid Fibrosarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) NCT05266196 | Salarius Pharmaceuticals, LLC | Phase 1 / Phase 2 |
| Recruiting | Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Proje NCT03967834 | Institut Claudius Regaud | N/A |
| Unknown | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcom NCT03600649 | Salarius Pharmaceuticals, LLC | Phase 1 |
| Active Not Recruiting | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |